NCT03875885 (CONNECT-HNC) is a NA clinical trial of CONNECT in Head and Neck Cancer, sponsored by Wake Forest University Health Sciences.

Who is sponsoring NCT03875885?

NCT03875885 is sponsored by Wake Forest University Health Sciences.

What drugs are being tested in NCT03875885?

Interventions in NCT03875885: CONNECT, CONTROL.

What condition does NCT03875885 study?

NCT03875885 studies Head and Neck Cancer.

Is NCT03875885 still recruiting?

NCT03875885 is currently completed. Last updated 27 April 2023.

Are results published for NCT03875885?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2023-04-27 · How we verify

NCT03875885: CONNECT-HNC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

CONNECTing Head and Neck Caregivers to Supportive Care Resources

Completed NA Results posted Last updated 27 April 2023

What this trial tests

NA trial testing CONNECT in Head and Neck Cancer in 40 participants. Completed in 31 May 2022.

Timeline

16 September 2020

Primary endpoint
31 May 2022

31 May 2022

Quick facts

Lead sponsor	Wake Forest University Health Sciences
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	40
Start date	16 September 2020
Primary completion	31 May 2022
Estimated completion	31 May 2022
Sites	1 location across United States

Drugs / interventions tested

CONNECT
CONTROL

Conditions studied

Head and Neck Cancer — all drugs for Head and Neck Cancer →

Sponsor

Wake Forest University Health Sciences

Who can join

18 and older, any sex, with Head and Neck Cancer. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Proportion of Caregivers Who Agree to Participate Primary · 19 months

Number of caregivers who agreed to participate divided by the number of months of recruitment

Group	Value	95% CI
Accrual	2.1

Number of Eligible Participants Primary · 9 months

Number of eligible participants who agreed to participate

Group	Value	95% CI
Participation	40

Number of Retention of Participants Primary · 9 months

Number of participants who completed the T2 assessment divided by the number who agreed to participate

Group	Value	95% CI
Retention	32

Acceptability - (Intervention Arm Only) Primary · 9 months

Survey developed for study to assess how much caregivers liked different aspects of CONNECT; and a \~30min (approximately) qualitative interview to further explore acceptability (measures were not at all helpful, a little helpful, somewhat helpful or quite a bit helpful).

Educational video on the CONNECT website (step 1 in guide)

Group	Value	95% CI
Acceptability (Intervention Arm Only)	1
Acceptability (Intervention Arm Only)	3
Acceptability (Intervention Arm Only)	5
Acceptability (Intervention Arm Only)	3

Online survey to identify the types of resources/services that might be helpful as a caregiver

Group	Value	95% CI
Acceptability (Intervention Arm Only)	2
Acceptability (Intervention Arm Only)	2
Acceptability (Intervention Arm Only)	4
Acceptability (Intervention Arm Only)	4

List of supportive care resources

Group	Value	95% CI
Acceptability (Intervention Arm Only)	2
Acceptability (Intervention Arm Only)	2
Acceptability (Intervention Arm Only)	5
Acceptability (Intervention Arm Only)	3

Referral option immediately upon completing the survey to identify resource interest

Group	Value	95% CI
Acceptability (Intervention Arm Only)	1
Acceptability (Intervention Arm Only)	2
Acceptability (Intervention Arm Only)	7
Acceptability (Intervention Arm Only)	2

2 week follow up phone call to discuss available resources

Group	Value	95% CI
Acceptability (Intervention Arm Only)	1
Acceptability (Intervention Arm Only)	2
Acceptability (Intervention Arm Only)	6
Acceptability (Intervention Arm Only)	1

Acceptability - (Intervention Arm Only) Primary · 9 months

Group	Value	95% CI
Acceptability (Intervention Arm Only)	2
Acceptability (Intervention Arm Only)	7
Acceptability (Intervention Arm Only)	5

Sponsor's own description

The purpose of this research is to determine feasibility and acceptability of randomized pilot trial to evaluate a technology-based intervention (CONNECT) to empower and educate caregivers about the benefits of supportive care resources, identify their unmet needs, and connect them with resources.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of CONNECT

Trials testing the same drug.

NCT02712229 — A Primary Palliative Care Intervention for Patients With Advanced Cancer · NA · completed

Other recruiting trials for Head and Neck Cancer

Currently open trials in the same condition.

NCT07318220 — Prehabilitation Protocol for Head and Neck Cancer Patients · NA · recruiting
NCT07524114 — Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception · recruiting
NCT07467083 — Development and Application of a Nurse-Led Preemptive Symptom Management Protocol for Head and Neck Cancer Patients Unde · Phase 3 · recruiting
NCT07209189 — Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-esca · Phase 2 · recruiting
NCT06837480 — Photobiomodulation in Head and Neck Cancer-Related Chronic Lymphedema · NA · recruiting

Other Wake Forest University Health Sciences trials

Trials by the same sponsor.

NCT07474090 — Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial · NA · not yet recruiting
NCT07282444 — A New Way to Share Radiation Therapy Plans Between Doctors, CORRECT Trial · NA · not yet recruiting
NCT06876896 — Intra-abdominal Pressure (IAP) During PFA Treatment of A-fib/ A-Flutter · NA · recruiting
NCT07227051 — Optimizing Self-Monitoring Feedback Delivery for the Treatment of Overweight and Obesity · NA · recruiting
NCT07215624 — Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03875885 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Wake Forest University Health Sciences
Last refreshed: 27 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03875885.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing